PARTNER THERAPEUTICS, INC.
LEXINGTON, Massachusetts
Total Received
$186.0M
Total Awards
6
State
Massachusetts
Last Updated
Mar 26, 2026
Yearly Funding Trend
$186.0M24
Top 6 Awards to PARTNER THERAPEUTICS, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 26, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_75A50323F80027_7505_36F79723D0171_3600 LEUKINE 250MCG QTY 14,635 AT THE UNIT PRICE OF $1,079.60 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | LEXINGTON, MA-05 | 2024 | $99,315,090 |
CONT_AWD_75A50322F80018_7505_36F79718D0593_3600 12-MONTH DO TO OBTAIN LEUKINE 250MCG/VIL INJ | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BOSTON, MA-07 | 2024 | $59,026,989 |
CONT_AWD_HHSO10033002T_7505_HHSO100201300005I_7505 CLOSE THE CONTRACT IN LINE WITH FAR 4.804 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | BRIDGEWATER, NJ-07 | 2024 | $13,943,972 |
CONT_AWD_75A50124C00061_7505_-NONE-_-NONE- PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS A… | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | LEXINGTON, MA-05 | 2024 | $12,990,717 |
CONT_AWD_75A50123C00064_7505_-NONE-_-NONE- R&D FOR REPURPOSING FX06, A HOST-DIRECTED THERAPY, FOR TREATMENT OF SEVERE DISEASE IN PATIENTS WITH SUDAN VIRUS DISEASE (SVD) OR OTHER FILOVIRUSES AOI #22 REBOOT | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | LEXINGTON, MA-05 | 2024 | $748,039 |
CONT_IDV_36F79723D0171_3600 2026 PUBLIC LAW PRICING UPDATES | Department of Veterans Affairs Department of Veterans Affairs | — | — | 2024 | $0 |
Top 6 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→1234
PHARMACEUTICAL PREPARATION MANUFACTURING$158.3M
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$13.9M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$13.0M
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$748K
Source: USAspending.gov · All Recipients · Massachusetts